Evoli Lisa
Known title: Executive Vice President &CHROCIK: 0001661715
Associated companies
Transaction History
| IART | ▼ Sell | Tax Withholding | 659 | $35K | 3/13/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 300 | $16K | 3/13/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 448 | $24K | 3/12/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 269 | $14K | 3/12/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 255 | $13K | 3/12/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 483 | $26K | 3/11/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 277 | $15K | 3/11/2023 | View on chart |
| IART | ▲ Buy | Grant | 2,532 | $0 | 3/10/2023 | View on chart |
| IART | ▼ Sell | Open Market | 3,767 | $215K | 2/27/2023 | View on chart |
| IART | ▲ Buy | Grant | 1,552 | $0 | 2/13/2023 | View on chart |
| IART | ▲ Buy | Grant | 632 | $0 | 2/13/2023 | View on chart |
| IART | ▲ Buy | Grant | 1,054 | $0 | 2/13/2023 | View on chart |
| IART | ▲ Buy | Grant | 1,137 | $0 | 2/13/2023 | View on chart |
| IART | ▼ Sell | Open Market | 1,165 | $65K | 8/10/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 293 | $16K | 8/3/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 456 | $26K | 8/1/2022 | View on chart |
| IART | ▼ Sell | Open Market | 900 | $50K | 6/15/2022 | View on chart |
| IART | ▼ Sell | Open Market | 250 | $15K | 5/24/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 188 | $12K | 3/13/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 115 | $7K | 3/13/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 430 | $28K | 3/13/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 704 | $46K | 3/13/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 164 | $11K | 3/12/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 394 | $26K | 3/12/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 657 | $43K | 3/12/2022 | View on chart |
| IART | ▲ Buy | Grant | 1,975 | $0 | 3/11/2022 | View on chart |
| IART | ▲ Buy | Grant | 7,680 | $0 | 3/11/2022 | View on chart |
| IART | ▼ Sell | Open Market | 1,254 | $84K | 2/28/2022 | View on chart |
| IART | ▲ Buy | Grant | 1,566 | $0 | 2/11/2022 | View on chart |
| IART | ▲ Buy | Grant | 2,566 | $0 | 2/11/2022 | View on chart |
| IART | ▲ Buy | Grant | 3,830 | $0 | 2/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
IART May Be 48% Undervalued Based on Cash Flow Analysis
A recent Yahoo analysis suggests Integra LifeSciences shares could be trading about 48% below their intrinsic value when cash flow is considered. The stock sits near its 13‑touch support level of $9.10 and an RSI of 41.6, indicating neither overbought nor oversold conditions. The average analyst target is $19.56, well above the current price, highlighting a potential valuation gap. This analysis may prompt a closer look at the company’s cash flow performance relative to market expectations.
IART May Be 48% Undervalued Based on Cash Flow Analysis. A recent Yahoo analysis suggests Integra LifeSciences shares could be trading about 48% below their intrinsic value when cash flow is considered. The stock sits near its 13‑touch support level of $9.10 and an RSI of 41.6, indicating neither overbought nor oversold conditions. The average analyst target is $19.56, well above the current price, highlighting a potential valuation gap. This analysis may prompt a closer look at the company’s cash flow performance relative to market expectations.